Treatment Registry
TR-0843 ActiveRecorded September 13, 2026

Brand tirzepatide

Sold by Wellorithm · Injection, pen · every brand tirzepatide record

What you actually pay

Per month

$1,199

Medication · Zepbound, monthly$1,199

Added from the figures recorded below.

Price

TermPer monthCharged today
Mounjaro, monthlyAdvertised

Mounjaro® Save up to $100 on your first order $1,399 per month See if you qualify Discount auto-applied at checkout

source

Per month$1,399Charged today$1,399
Zepbound, monthly

Zepbound Save up to $100 on your first order $1,199 per month See if you qualify Discount auto-applied at checkout

source

Per month$1,199Charged today$1,199
Enroll with Wellorithm

This is a paid link. If you enroll through it, Treatment Registry may earn a commission. It does not change what we record, and it does not change the price you pay.

History

One reading so far. A price history appears here after the next verification pass.

  • September 13, 2026Entry added to the register

Sourcing and terms

PharmacyNot disclosed
StatesNot disclosed
PrescriberAsynchronous review
MembershipNone. “No membership fees. Same price at every dose.”
Consult feeNot disclosed

Not yet checked: cancellation.

Recorded from wellorithm.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 13, 2026Wellorithm's affiliate lander at /campaign-7 publishes no price at all, and its product pages publish one each. The lander was read in a browser before that was concluded, because a fetcher sees an empty shell on this site. Every figure here is a brand-name drug dispensed in the manufacturer's own pen, not a compounded preparation, which is why they sit an order of magnitude above the compounded programs elsewhere in the register. Each page also offers “Save up to $100 on your first order” with the discount auto-applied at checkout, so a first bill may be lower than the figure recorded.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0843
Readings
1

Related records

What else Wellorithm sells

All Wellorithm programs and terms

Brand tirzepatide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 59 records of the same molecule.

Cite this entry

Treatment Registry. (2026). Wellorithm brand tirzepatide (TR-0843). Last verified September 13, 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0843

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.